Antibodies directed against nerve growth factor-like peptides
CA 2024063 C · Owner: Fukuda, Tsunehiko · Inventors: Kuroshima, Ken-Ichi; Kurokawa, Tsutomu; Fukuda, Tsunehiko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are (A) an antibody to a peptide including at least 8 successive amino acids of an amino acid sequence represented by formula (I):, TyrAlaGluHisLysSerHisArgGlyGluTyrSerValCys AspSerGluSerLeuTrpValThrAspLysSerSerAlaIle AspIleArgGlyHisGlnValThrValLeuGlyGluIleLys ThrGlyAsnSerProValLysGlnTyrPheTyrGluThrArg CysLysGluAlaArgProValLysAsnGlyCysArgGlyIle AspAspLysHisTrpAsnSerGlnCysLysThrSerGlnThr TyrValArgAlaLeuThrSerGluAsnAsnLysLeuValGly TrpArgTrpIleArgIleAspThrSerCysValCysAlaLeu SerArgLysIleGlyArg I, (B) a method for producing the antibody (C) a cloned, hybridoma which produces the antibody (D) a method for, producing the cloned hybridoma (E) a partial peptide of the, polypeptide (I) …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 27, 1990 and granted July 16, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 27, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 27, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.